Olagunju Peter 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 9, 2022
Insider Transaction Report
Form 4
Olagunju Peter
Chief Technical Officer
Transactions
- Sale
Common Stock
2022-12-08$1.25/sh−1,410$1,767→ 28,922 total - Sale
Common Stock
2022-12-07$1.28/sh−1,378$1,767→ 30,332 total
Holdings
- 31,710
Common Stock
Footnotes (1)
- [F1]The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.